Articles of Science

News »

Cuba presents another COVID-19 candidate vaccine

cuba vacuna

Biotechnology made in Cuba shows its strengths once again. The Center for Genetic Engineering and Biotechnology (CIGB) has submitted the technical file of their first vaccine candidate against COVID-19 to the State Center for the Control of Medicines, Medical Equipment and Devices (CECMED).

News »

The emergence of Soberana 1 is not a chance event

Cuba vacuna

Since the beginning of the Revolution, the priority granted to scientific progress, with emphasis on the training of highly qualified human capital and the creation of research centers in dissimilar branches of knowledge, were essential prerequisites that allowed Cuba to venture into the promising sector of biotechnology in the decade of the 1980s, practically at the same time this industry was emerging in a small group of nations with greater technological development.

News »

BioCen develops secure medium to transport viral samples, a first in Cuba

vacuna covid

Researchers at the National Biopreparations Center (BioCen) have developed Cuba’s first secure medium to transport viruses, created for use in the collection and transfer of patients’ nasopharyngeal and oropharyngeal samples for the diagnosis of SARS-COV-2, the COVID-19 causal agent. BioCen achieved and industrially scaled the product in only seven days and, subsequently received its Sanitary Registration from the State Center for the Control of Drugs, Equipment and Medical Devices (Cecmed).

News »

Molecular biology laboratory inaugurated in Ciego de Ávila

centro-biologia-molecular ciego

With the opening today of a molecular biology laboratory at the Roberto Rodríguez hospital, in the municipality of Morón, in Ciego de Ávila , Cuba brings to 12 facilities of this type that process samples for the detection of the SARS-CoV-2 virus, in as well as three others enlist in Holguín , Matanzas and Isla de la Juventud.

News »

Second group of volunteers join Soberana clinical trials

Cartel vacuna

Twenty more Cubans joined the short history of Soberana 01, the country’s first candidate vaccine against COVID-19, on September 2, according to reports from Naturaleza Secreta. This group, composed of volunteers between 60 and 80 years of age, is the second to receive the first dose of the much awaited vaccine.

News »

Soberana in the first phase of clinical trials

Soberana vacuna

The first stage of clinical trials for the definitive validation of Soberana, the Cuban candidate vaccine authorized to begin this phase, began August 24, with the administration of the product to 20 volunteers, between the age of 19 and 59. Over the course of the week, the safety of the candidate vaccine was evaluated and the findings submitted to the Center for State Control of Medications (Cecmed)

News »

Soberana is Cuba’s, the first candidate vaccine against COVID-19 in Latin America and the Caribbean

Covid vacuna cartel

A vaccine that exemplifies the development of Cuban science; that places us on the level of economically advanced countries; that honors Comandante en Jefe Fidel Castro Ruz, the principal architect of the country’s biotechnology sector. This is what Soberana is, the first Cuban candidate vaccine against COVID-19 authorized for testing in clinical trials.

News »

Díaz-Canel meets with Cuban scientists working on COVID-19 candidate vaccines

canel artemisa

The President of the Republic, Miguel Díaz-Canel Bermúdez, recently held a discussion with a group of scientists working on the development of COVID-19 candidate vaccines, to contain the dangerous illness that has caused the deaths of more than 766,000 persons around the world, 88 in our nation.

News »

The Cuban pharmaceutical industry vs COVID-19

vacunas-rusia-covid-19- 300

The Cuban pharmaceutical industry has been key to the national strategy to confront the SARS-COV-2 pandemic, guaranteeing medications to implement treatment protocols established by the Ministry of Public Health (Minsap), including several products used successfully with high-risk segments of the population, reducing the number of patients reaching serious and critical conditions, as well as mortality rates for this group.

News »

BioFarma Innovations, a new joint enterprise created by BioCubaFarma and SG Innovations Limited

Cuba biofarma

The new partnership aims to provide broader access to BioCubaFarma’s patent-protected portfolio of biopharmaceutical products, developed by the pharmaceutical and biotechnology industry in Cuba. Cuba’s BioCubaFarma Enterprise Group and the British company SG Innovations Limited has announced the creation of a new company, BioFarma Innovations focused on accelerating the development of new medications and their distribution in Europe and the British Commonwealth.